Clinical Trials

Search for actively enrolling clinical trials

Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants

Study ID: STU-2019-1329

Summary

This study will be a randomized, double blind, placebo controlled multicenter trial. The target enrollment will be 108 randomized subjects.

Cancer Related
Healthy Volunteers
No
UT Southwestern Principal Investigator
KENNETH H LEE

Contact:

Katherine Bosler

Katherine.Bosler@UTSouthwestern.edu

Linked In Email
scroll to top